주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-18 16:23 (Thurs)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Policy
목록
(
총 :
618 )
기사목록 보기 형태
제목형
요약형
포토형
KHIDI to collaborate with UK's Medical Research Council for healthcare research
Lee Han-soo
2024.03.15 16:36
Seoul to stop providing free Covid-19 drugs amid reimbursement delays
Kim Yun-mi
2024.03.15 11:02
Seoul prioritizes distribution of immunoglobulin to children's hospitals
Kwak Sung-sun
2024.03.15 10:53
'Study pressure, screen time exacerbate sleep deficit in Korean teens'
You Ji-young
2024.03.14 13:22
Court to decide whether to suspend medical student increase as early as Friday this week
Koh Jung Min
2024.03.11 16:14
APAC CVD Alliance report highlights Korea's strides in fighting cardiovascular diseases amid economic strain
Lee Han-soo
2024.03.08 09:37
Korea mobilizes over ₩200 billion per month to maintain emergency care
Lee Han-soo
2024.03.07 17:15
Korea's health insurance panel denies coverage for new cancer drugs
Kim Yun-mi
2024.03.07 15:38
Cram schools capitalize on med school quota to attract office workers into medical programs
Kim Ju-yeon
2024.03.07 14:52
Med school professors sue health, education ministers to nix student quota hike
Koh Jung Min
2024.03.06 11:04
Prof. Park Yeong-min of Sejong University named KDDF’s 2nd CEO
Kim Chan-hyuk
2024.03.05 16:03
40 med schools request additional 3,401 student enrollment for 2025 academic year
Kim Eun-young
2024.03.05 15:15
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기